National Aeronautics and Space Administration (NASA) for the first time has successfully sequenced DNA in space aboard the International Space Station (ISS). The genome sequencing was undertaken for the first time in microgravity as part of the Biomolecule Sequencer experiment performed by NASA astronaut Kate Rubins.
- The experiments were undertaken by using commercially available DNA sequencing device called MinION on samples of mouse, virus and bacteria DNA.
- The tests were set up for selected organisms whose DNA has already been completely sequenced in an attempt to make spaceflight conditions, primarily microgravity, the only variables that could account for differences in results. The technology demonstration experiments validated that the device is durable enough to withstand vibration during launch and can operate reliably in a microgravity environment.